Molecular Templates is focused on the discovery, development, and commercialization of a next-generation of immunotoxins called ETBs for the treatment of cancer

Biotechnology

Molecular Templates

Molecular Templates' headquarters in Georgetown, TX, United States

Eric Poma

Grace Kim

Kogan Bao

Joseph Phillips

Jason Kim

David R. Hoffmann

Kevin M. Lalande

Corsee D. Sanders

Jonathan Lanfear

Harold E. Selick

Gabriela Gruia

The Board of Directors at Molecular Templates oversees the strategic direction and governance of the company, ensuring alignment with its mission to discover, develop, and commercialize next-generation immunotoxins (ETBs) for cancer treatment. The board provides high-level guidance, makes key decisions, and supports executive management in achieving organizational objectives.

Board of Directors

The Scientific Research and Development Team at Molecular Templates focuses on the discovery and development of Engineered Toxin Bodies (ETBs) for cancer treatment. They are involved in downstream and upstream process development, pre-clinical pharmacology, molecular biology, and translational medicine. Their work includes designing experiments, conducting clinical studies, and optimizing manufacturing processes to advance ETBs from early-stage research through clinical trials and toward commercialization.

Scientific Research and Development Team

This department focuses on the research and development of upstream and downstream processing techniques in scientific applications.

Process Development

This department focuses on advancing scientific knowledge and innovative solutions through research and experimentation.

Research and Development

The Biopharmaceutical Development Team at Molecular Templates is responsible for advancing the company's proprietary engineered toxin bodies (ETBs) from preclinical stages through clinical development. This includes optimizing protein sciences, ensuring robust CMC (Chemistry, Manufacturing, and Controls) processes, and translating preclinical findings into clinical strategies to effectively treat cancer.

Biopharmaceutical Development Team

The Clinical Development Team at Molecular Templates is responsible for designing, managing, and overseeing clinical trials to evaluate the safety and efficacy of ETBs (Engineered Toxin Bodies) for cancer treatment. This team ensures seamless project execution, data integrity, regulatory compliance, and effective communication of clinical findings to support the advancement of novel cancer therapies.

Molecular Templates

Org chart

Board & advisors

Teams

Board of Directors

Scientific Research and Development Team

Process Development

Research and Development

Biopharmaceutical Development Team

Clinical Development Team

Offices

Molecular Templates

Org chart

Board & advisors

Teams

Board of Directors

Scientific Research and Development Team

Process Development

Research and Development

Biopharmaceutical Development Team

Clinical Development Team

Offices

Related companies